help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Published ahead of print on May 30, 2003, doi:10.1165/rcmb.2003-0028OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-0028OCv1
29/5/571    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Umland, S. P.
Right arrow Articles by Ralston, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Umland, S. P.
Right arrow Articles by Ralston, R.
American Journal of Respiratory Cell and Molecular Biology. Vol. 29, pp. 571-582, 2003
© 2003 American Thoracic Society
DOI: 10.1165/rcmb.2003-0028OC

Human ADAM33 Messenger RNA Expression Profile and Post-Transcriptional Regulation

Shelby P. Umland, Charles G. Garlisi, Himanshu Shah, Yuntao Wan, Jun Zou, Kristine E. Devito, Whei-Mei Huang, Eric L. Gustafson and Robert Ralston

Departments of Allergy and Human Genomics, Schering-Plough Research Institute, Kenilworth, New Jersey; and Canji Inc., San Diego, California

Address correspondence to: Shelby P. Umland, Ph.D., Schering-Plough Research Institute, 2015 Galloping Hill Road, K15-1-1700, Kenilworth, NJ 07033. E-mail: shelby.umland{at}spcorp.com

We examined transcript expression and post-transcriptional regulation of human ADAM33, a recently identified asthma gene. A detailed messenger RNA (mRNA) expression profile was obtained using Northern, reverse transcription polymerase chain reaction, and in situ hybridization analyses. ADAM33 mRNA was expressed significantly in smooth muscle–containing organs, minimally in immune organs and hematopoietic cells, and highly in repairing duodenal granulation tissue. Expression was seen in asthmatic subepithelial fibroblasts and smooth muscle but not in respiratory epithelium. In all tissues, transcripts of ~ 5 kb predominated over those of ~ 3.5 kb by 2- to 5-fold. The effect of the 3' untranslated region (UTR) on ADAM33 protein expression and maturation was examined. The presence of the 3'UTR in untagged full-length constructs promoted prodomain removal, detected as mature ~ 100 kD protein by ADAM33-reactive antibodies; in its absence, maturation was 2- to 3-fold less in HEK293 cells. His-tagged and untagged constructs lacking the 3'UTR demonstrated that lack of maturation was not a result of tag-mediated effects. Minimal maturation of ADAM33 occurred in primary lung and MRC5 fibroblasts following adenoviral-mediated expression of ADAM33 lacking the 3'UTR. In contrast, prodomain removal was observed with plasmids and adenovirus encoding only the pro- and catalytic domains. Thus, the 3'UTR of ADAM33 and domains downstream of the catalytic domain regulate potential ADAM33 activity. Mechanisms of regulation of ADAM33, distinct from closely related ADAMs, thus include mRNA localization and processing and protein maturation.

Abbreviations: antibody, Ab • a distintegrin and metalloprotease, ADAM • bronchial smooth muscle cells, BSMC • complimentary DNA, cDNA • Chinese hamster kidney cells, CHO-K1 • cycle threshold, Ct • epidermal growth factor, EGF • human embryonic kidney cells, HEK • a tag of six histidine residues, his • messenger RNA, mRNA • normal human lung fibroblasts, NHLF • in situ hybridization, ISH • polymerase chain reaction, PCR • recombinant adenovirus, rAd • reverse transcription PCR, RT-PCR • Tris-buffered saline, TBS • TBS with 0.1% Tween 20, TBS-T • tumor necrosis factor, TNF • untranslated region, UTR




This article has been cited by other articles:


Home page
 Postgrad. Med. J.Home page
F. Sampsonas, A. Kaparianos, D. Lykouras, K. Karkoulias, and K. Spiropoulos
DNA sequence variations of metalloproteinases: their role in asthma and COPD
Postgrad. Med. J., April 1, 2007; 83(978): 244 - 250.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
M. M E Gosman, H Marike Boezen, C. C van Diemen, J. B Snoeck-Stroband, T. S Lapperre, P. S Hiemstra, N. H T ten Hacken, J. Stolk, D. S Postma, and the GLUCOLD Study Group
A disintegrin and metalloprotease 33 and chronic obstructive pulmonary disease pathophysiology
Thorax, March 1, 2007; 62(3): 242 - 247.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J.-Y. Lee, S.-W. Park, H. K. Chang, H. Y. Kim, T. Rhim, J.-H. Lee, A.-S. Jang, E.-S. Koh, and C.-S. Park
A Disintegrin and Metalloproteinase 33 Protein in Patients with Asthma: Relevance to Airflow Limitation
Am. J. Respir. Crit. Care Med., April 1, 2006; 173(7): 729 - 735.
[Abstract] [Full Text] [PDF]

Home page
 Phil Trans R Soc BHome page
J. Kere
Mapping and identifying genes for asthma and psoriasis
Phil Trans R Soc B, August 29, 2005; 360(1460): 1551 - 1561.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
C. C. van Diemen, D. S. Postma, J. M. Vonk, M. Bruinenberg, J. P. Schouten, and H. M. Boezen
A Disintegrin and Metalloprotease 33 Polymorphisms and Lung Function Decline in the General Population
Am. J. Respir. Crit. Care Med., August 1, 2005; 172(3): 329 - 333.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. Simpson, N. Maniatis, F. Jury, J. A. Cakebread, L. A. Lowe, S. T. Holgate, A. Woodcock, W. E. R. Ollier, A. Collins, A. Custovic, et al.
Polymorphisms in A Disintegrin and Metalloprotease 33 (ADAM33) Predict Impaired Early-Life Lung Function
Am. J. Respir. Crit. Care Med., July 1, 2005; 172(1): 55 - 60.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. M. Haitchi, R. M. Powell, T. J. Shaw, P. H. Howarth, S. J. Wilson, D. I. Wilson, S. T. Holgate, and D. E. Davies
ADAM33 Expression in Asthmatic Airways and Human Embryonic Lungs
Am. J. Respir. Crit. Care Med., May 1, 2005; 171(9): 958 - 965.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
S T Holgate and J W Holloway
Is big beautiful? The continuing story of ADAM33 and asthma
Thorax, April 1, 2005; 60(4): 263 - 264.
[Full Text] [PDF]

Home page
 ThoraxHome page
J Blakey, E Halapi, U S Bjornsdottir, A Wheatley, S Kristinsson, R Upmanyu, K Stefansson, H Hakonarson, and I P Hall
Contribution of ADAM33 polymorphisms to the population risk of asthma
Thorax, April 1, 2005; 60(4): 274 - 276.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
B. A. Raby and S. T. Weiss
ADAM33: Where Are We Now?
Am. J. Respir. Cell Mol. Biol., July 1, 2004; 31(1): 1 - 2.
[Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
R. M. Powell, J. Wicks, J. W. Holloway, S. T. Holgate, and D. E. Davies
The Splicing and Fate of ADAM33 Transcripts in Primary Human Airways Fibroblasts
Am. J. Respir. Cell Mol. Biol., July 1, 2004; 31(1): 13 - 21.
[Abstract] [Full Text] [PDF]

Home page
 QJMHome page
S.T. Holgate
Lessons learnt from the epidemic of asthma
QJM, May 1, 2004; 97(5): 247 - 257.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Zou, F. Zhu, J. Liu, W. Wang, R. Zhang, C. G. Garlisi, Y.-H. Liu, S. Wang, H. Shah, Y. Wan, et al.
Catalytic Activity of Human ADAM33
J. Biol. Chem., March 12, 2004; 279(11): 9818 - 9830.
[Abstract] [Full Text] [PDF]

Home page
 JRSMHome page
S. T Holgate
The epidemic of asthma and allergy
J R Soc Med, March 1, 2004; 97(3): 103 - 110.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2003 American Thoracic Society. 		  CCM abstracts